Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Valaciclovir reduces CMV in kidney transplant recipients

June 9, 1999

Versicor licenses antifungal compound from Lilly

June 4, 1999

TerraGen establishes second collaboration with Schering-Plough

June 4, 1999

Relenza receives approval in the E.U. for treatment of influenza

June 3, 1999

Warner-Lambert synthesizes antibacterial substituted quinazoline-2,4-diones

June 3, 1999

Anti-MRSA trinems designed at Merck & Co.

June 3, 1999

FDA gives green light for Core's pivotal studies on metronidazole Hycore-V

June 2, 1999

Another series of naphthosultam-substituted carbapenems in development at Merck

June 2, 1999

Hollis-Eden and U.S. Naval Medical Center collaborate on malaria research

June 2, 1999

Carbapenems from Merck especially useful against resistant bacteria

June 1, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...